Scott E. Lentz

Multi-Institutional Reciprocal Validation Study of Computed Tomography Predictors of Suboptimal Primary Cytoreduction in Patients With Advanced Ovarian Cancer

Allison E. Axtell, Margaret H. Lee, Robert E. Bristow et al. · Journal of Clinical Oncology · 2007 · 245 citations · Full text

Medicine, Oncology, Surgery +15

Occult Uterine Sarcoma and Leiomyosarcoma

Tina Raine‐Bennett, Lue‐Yen Tucker, Eve Zaritsky et al. · Obstetrics and Gynecology · 2015 · 116 citations

Medicine, Oncology, Surgery +14

Identification of Micrometastases in Histologically Negative Lymph Nodes of Early-Stage Cervical Cancer Patients

Scott E. Lentz, Laila I. Muderspach, Wei Ye et al. · Obstetrics and Gynecology · 2004 · 91 citations

Medicine, Oncology, Pathology +17

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

Ignace Vergote, Giovanni Scambia, David M. O’Malley et al. · The Lancet Oncology · 2019 · 86 citations · Full text

Medicine, Gynecology, Oncology +11

Same-day discharge is feasible and safe in patients undergoing minimally invasive staging for gynecologic malignancies

K. Penner, Nicole D. Fleming, L. Barlavi et al. · American Journal of Obstetrics and Gynecology · 2014 · 81 citations

Medicine, Gynecology, Surgery +13